tetano
Editor, Senior Moderator
Pediatr Neonatol
. 2023 Oct 21:S1875-9572(23)00178-X.
doi: 10.1016/j.pedneo.2023.02.009. Online ahead of print. In-hospital care of children with COVID-19
Oi-Wa Chan[SUP] 1 [/SUP], En-Pei Lee[SUP] 1 [/SUP], Cheng-Che Chou[SUP] 2 [/SUP], Shen-Hao Lai[SUP] 3 [/SUP], Hung-Tao Chung[SUP] 4 [/SUP], Jung Lee[SUP] 5 [/SUP], Jainn-Jim Lin[SUP] 1 [/SUP], Kai-Sheng Hsieh[SUP] 6 [/SUP], Shao-Hsuan Hsia[SUP] 7 [/SUP]
Affiliations
Children have been reported to be less affected and to have milder severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection than adults during the coronavirus disease 2019 (COVID-19) pandemic. However, children, and particularly those with underlying disorders, are still likely to develop critical illnesses. In the case of SARS-CoV-2 infection, most previous studies have focused on adult patients. To aid in the knowledge of in-hospital care of children with COVID-19, this study presents an expert review of the literature, including the management of respiratory distress or failure, extracorporeal membrane oxygenation (ECMO), multisystem inflammatory syndrome in children (MIS-C), hemodynamic and other organ support, pharmaceutical therapies (anti-viral drugs, anti-inflammatory or antithrombotic therapies) and management of cardiopulmonary arrest.
Keywords: COVID-19; cardiopulmonary arrest; extracorporeal membrane oxygenation (ECMO); hemodynamic and other organ support; multisystem inflammatory syndrome in children (MIS-C); pharmaceutical therapy; respiratory distress or failure.
. 2023 Oct 21:S1875-9572(23)00178-X.
doi: 10.1016/j.pedneo.2023.02.009. Online ahead of print. In-hospital care of children with COVID-19
Oi-Wa Chan[SUP] 1 [/SUP], En-Pei Lee[SUP] 1 [/SUP], Cheng-Che Chou[SUP] 2 [/SUP], Shen-Hao Lai[SUP] 3 [/SUP], Hung-Tao Chung[SUP] 4 [/SUP], Jung Lee[SUP] 5 [/SUP], Jainn-Jim Lin[SUP] 1 [/SUP], Kai-Sheng Hsieh[SUP] 6 [/SUP], Shao-Hsuan Hsia[SUP] 7 [/SUP]
Affiliations
- PMID: 37989708
- DOI: 10.1016/j.pedneo.2023.02.009
Children have been reported to be less affected and to have milder severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection than adults during the coronavirus disease 2019 (COVID-19) pandemic. However, children, and particularly those with underlying disorders, are still likely to develop critical illnesses. In the case of SARS-CoV-2 infection, most previous studies have focused on adult patients. To aid in the knowledge of in-hospital care of children with COVID-19, this study presents an expert review of the literature, including the management of respiratory distress or failure, extracorporeal membrane oxygenation (ECMO), multisystem inflammatory syndrome in children (MIS-C), hemodynamic and other organ support, pharmaceutical therapies (anti-viral drugs, anti-inflammatory or antithrombotic therapies) and management of cardiopulmonary arrest.
Keywords: COVID-19; cardiopulmonary arrest; extracorporeal membrane oxygenation (ECMO); hemodynamic and other organ support; multisystem inflammatory syndrome in children (MIS-C); pharmaceutical therapy; respiratory distress or failure.